These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 2664021)
1. Serum levels of CA 72.4, CEA and CA 19.9 in patients with colorectal carcinoma. Preliminary results. Jiménez-Heffernan A; Torres M; González FM; Mateo A Int J Biol Markers; 1989; 4(1):53-4. PubMed ID: 2664021 [No Abstract] [Full Text] [Related]
2. Comparison of serum assays for TAG-72, CA19-9 and CEA in gastrointestinal carcinoma patients. Ohuchi N; Takahashi K; Matoba N; Sato T; Taira Y; Sakai N; Masuda M; Mori S Jpn J Clin Oncol; 1989 Sep; 19(3):242-8. PubMed ID: 2810823 [TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of CA-50 in cases with colorectal cancer]. Nishida O; Ohmori K; Shiroto H; Sawaguchi Y; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J Gan No Rinsho; 1989 Apr; 35(5):605-8. PubMed ID: 2654447 [TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of a combination assay of CEA, CA-19-9 and TPA in patients with colorectal cancer]. Nishida O; Shiroto H; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J Gan No Rinsho; 1988 Aug; 34(9):1096-100. PubMed ID: 3172515 [TBL] [Abstract][Full Text] [Related]
5. [The value of tumor markers in colorectal cancer]. Peters KM; Grundmann R Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234 [TBL] [Abstract][Full Text] [Related]
6. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma. Forslund A; Engarås B; Lönnroth C; Lundholm K Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598 [TBL] [Abstract][Full Text] [Related]
7. Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease. Lindhorst E Tumour Biol; 2000; 21(2):116-22. PubMed ID: 10686541 [TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen and breast carcinoma antigen (CA 15.3) in preoperative staging and postoperative monitoring of patients with carcinoma of the breast. Omar YT; Behbehani AE; al-Naqeeb N; Motawy MM; Folldi MO; Awwad AH; Nasralla MY; Szymendera JJ Int J Biol Markers; 1988; 3(3):165-71. PubMed ID: 3230336 [TBL] [Abstract][Full Text] [Related]
9. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis]. Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of CA 19.9 levels in colorectal cancer. Filella X; Molina R; Grau JJ; Piqué JM; Garcia-Valdecasas JC; Astudillo E; Biete A; Bordas JM; Novell A; Campo E Ann Surg; 1992 Jul; 216(1):55-9. PubMed ID: 1632702 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of colorectal cancer-associated mucin CA M43 assay in serum. van Kamp GJ; von Mensdorff-Pouilly S; Kenemans P; Verstraeten R; Yedema CA; Wobbes T; Bon GG; Kok A; Brown JP; Hilgers J Clin Chem; 1993 Jun; 39(6):1029-32. PubMed ID: 8504532 [TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen, CA 19-9 and CA 50 in monitoring human squamous cell carcinoma of the esophagus. Munck-Wikland E; Kuylenstierna R; Lindholm J; Wahren B Anticancer Res; 1990; 10(3):703-8. PubMed ID: 2369087 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Zhang SY; Lin M; Zhang HB Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695 [TBL] [Abstract][Full Text] [Related]
14. CEA and CA 19.9 in gastric juice and serum: an aid in the diagnosis of gastric carcinoma? Harrison JD; Stanley J; Morris DL Eur J Surg Oncol; 1989 Jun; 15(3):253-7. PubMed ID: 2737312 [TBL] [Abstract][Full Text] [Related]
15. Significance of CA72.4 in patients with colorectal cancer. Comparison with CEA and CA19.9. Filella X; Molina R; Mengual PJ; Jo J; Ballesta AM J Nucl Biol Med (1991); 1991; 35(3):158-61. PubMed ID: 1816871 [TBL] [Abstract][Full Text] [Related]
16. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix. Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225 [TBL] [Abstract][Full Text] [Related]
17. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma. Harmenberg U; Frödin JE; Ljungdahl-Stähle E; Mellstedt H; Wahren B; Stigbrand T Tumour Biol; 1989; 10(5):225-31. PubMed ID: 2814231 [TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas. Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184 [TBL] [Abstract][Full Text] [Related]
19. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer. Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of the T.A.T.I. marker with CEA and Ca 19-9 in neoplasms of the gastrointestinal system. Preliminary data]. Ricci E; Pecchio F; Rapellino M; Giaccone M; Adamo R; Boltri F; Oliaro A Minerva Dietol Gastroenterol; 1988; 34(4):217-20. PubMed ID: 3247053 [No Abstract] [Full Text] [Related] [Next] [New Search]